These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 23802311)
1. Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill. Palacios S; Colli E; Regidor PA Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1549-1557. PubMed ID: 31321765 [TBL] [Abstract][Full Text] [Related]
2. Drospirenone-containing oral contraceptives may increase the risk of venous thromboembolism. Jick SS Evid Based Nurs; 2014 Jul; 17(3):71. PubMed ID: 24170817 [No Abstract] [Full Text] [Related]
3. Acute myocardial infarction associated with Yasmin oral contraceptive. Ortà G; Mira Y; Vaya A Clin Appl Thromb Hemost; 2007 Jul; 13(3):336-7. PubMed ID: 17636199 [No Abstract] [Full Text] [Related]
4. Commentary on "Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review". Cameron S BJOG; 2013 Jun; 120(7):811. PubMed ID: 23802311 [No Abstract] [Full Text] [Related]
5. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. Wu CQ; Grandi SM; Filion KB; Abenhaim HA; Joseph L; Eisenberg MJ BJOG; 2013 Jun; 120(7):801-10. PubMed ID: 23530659 [TBL] [Abstract][Full Text] [Related]